Amesite Inc. (AMST) Stock Price & Analysis
Amesite Inc. (AMST) rose 3.20% to USD 1.29 as of June 10, 2026 at 02:18 UTC, according to Nexqual real-time market data.
AMST last closed at USD 1.25; the session ranged USD 1.21–1.3 on volume of 140,256 shares. Market capitalization is $7.55M, with a 52-week range of USD 0.77–4.78 (NCM). Source: Nexqual, June 10, 2026 at 02:18 UTC.
Key Statistics (as of June 10, 2026 at 02:18 UTC)
| Price | USD 1.29 |
|---|---|
| Change | ▲ 3.20% (up) |
| Previous Close | USD 1.25 |
| Open | USD 1.27 |
| Day Range | USD 1.21 – 1.3 |
| 52-Week Range | USD 0.77 – 4.78 |
| Volume | 140,256 shares |
| Market Cap | $7.55M |
| Exchange | NCM |
Technical Analysis (AMST)
Nexqual's technical model rates AMST "SELL" based on 2 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 02:18 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.25 (neutral) |
| vs SMA50 | Below (USD 1.42) |
| MACD | 0 (positive) |
Analyst Ratings (AMST)
Wall Street analysts rate AMST "None", per Nexqual as of June 10, 2026 at 02:18 UTC.
| Consensus Rating | None |
|---|
Earnings (AMST)
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Financials & Fundamentals (AMST)
| Total Revenue | $341,437 |
|---|---|
| Revenue Growth (YoY) | +171.50% |
| Gross Margin | +100.00% |
| Operating Margin | -820.90% |
| Profit Margin | +0.00% |
| ROE | -121.49% |
| Current Ratio | 4.33 |
| Total Cash | $640,711 |
| Total Debt | $0 |
| Free Cash Flow | $-1.38M |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Financial Health Score (AMST)
Nexqual rates Amesite Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:18 UTC.
| Growth | Strong — Revenue +172% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $641K cash, no debt |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Critical — ROE -121%, ROA -69.5% |
Ownership (AMST)
| Insider Ownership | +36.86% |
|---|---|
| Institutional Ownership | +5.58% |
| Shares Outstanding | 5.85M |
| Float | 3.62M |
| Short % of Float | +15.42% |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Leadership (AMST)
Amesite Inc. is led by Ann Marie Sastry (age 57), Chairperson, President & CEO, per Nexqual as of June 10, 2026 at 02:18 UTC.
| Chairperson, President & CEO | Ann Marie Sastry (age 57) |
|---|
Major Backers & Investors (AMST)
Notable institutional backers of Amesite Inc. include Focus Partners Wealth, Fidelity, Xtx Topco Ltd, according to Nexqual as of June 10, 2026 at 02:18 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Focus Partners Wealth | 2.84% |
| Fidelity | 0.81% |
| Xtx Topco Ltd | 0.17% |
| Osaic Holdings Inc. | 0.17% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.28% |
| Geode Capital | 0.92% |
| State Street | 0.54% |
| Dimensional Fund Advisors | 0.11% |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
From Amesite Inc.'s Latest SEC 10-K Filing (filed 2025-09-29)
Key Strengths & Strategy (as disclosed to the SEC)
- Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States.
- Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AUUD | Auddia Inc. | USD 1.3 | ▼ 0.76% |
| IFBD | Infobird Co., Ltd | USD 1.12 | ▲ 21.74% |
| PRFX | PRF Technologies Ltd. | USD 1.42 | ▼ 10.69% |
| INM | InMed Pharmaceuticals Inc. | USD 1.53 | ▼ 3.16% |
| AEHL | Antelope Enterprise Holdings Li | USD 1.02 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:18 UTC. This page is informational and not investment advice.